Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Junaid Arshad
Assistant Professor, Medicine - (Clinical Scholar Track)
Medicine
Full Page
Overview
Research
More
Collaboration
(22)
Denise Roe
Mutual work: 1 Proposal
Collaboration Details
Rachna Shroff
Mutual work: 28 Proposals
Collaboration Details
Ritu Pandey
Mutual work: 1 Proposal
Collaboration Details
Juanita Merchant
Mutual work: 6 Proposals
Collaboration Details
Gregory Woodhead
Mutual work: 1 Proposal
Collaboration Details
Page 1 of 5
Previous page
Next page
Publications
(27)
Recent
A unique case of unresectable metastatic gastric squamous cell carcinoma treated with combined nivolumab and capecitabine/oxaliplatin complicated by immunotherapy induced pure …
2024
cancer,
immunotherapy,
treatment,
metastasis,
chemotherapy
Cabozantinib changes the tumor microenvironment to increase the efficacy of immunotherapy in refractory metastatic pancreatic ductal adenocarcinoma
2024
immunotherapy,
pancreatic cancer,
tumor microenvironment,
metastatic cancer
Biomarker Testing and Role of Tyrosine Kinase Inhibitors and Immunotherapy for Esophageal Squamous Cell Carcinoma
2024
cancer,
biomarkers,
immunotherapy,
tyrosine kinase inhibitors,
esophageal cancer
Concurrent Stage III Unresectable Duodenal Adenocarcinoma and Metastatic Gastrointestinal Stromal Tumor Treated With Combination of Imatinib and mFOLFIRI
2024
cancer,
treatment,
gastrointestinal,
metastatic tumors
Mo1242 TADALAFIL REDUCES SLFN12L+MYELOID-DERIVED SUPPRESSOR CELLS AND INCREASES EFFECTOR T CELLS IN PATIENTS ENROLLED IN A WINDOW STUDY OF GASTRIC CANCER TREATMENT
2024
immunotherapy,
immunosuppression
Modifying the gastric tumor microenvironment with tadalafil: A transcriptomic analysis of immune signatures from underserved patients of southern Arizona.
2024
gastrointestinal cancer,
transcriptomic analysis,
immune response,
underserved populations,
drug therapy
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers
2024
immunotherapy,
cancer,
gastrointestinal,
cell biology,
therapeutics
Efficacy of Bisphosphonates in Reducing Fracture Risk Among Postmenopausal Women With Osteoporosis
2024
fracture risk,
postmenopausal women,
osteoporosis,
efficacy
Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.
2023
cancer immunotherapy,
health disparities,
clinical research,
oncology
Outcomes for immuno-chemotherapy based treatment in patients with poorly differentiated extrapulmonary neuroendocrine carcinoma.
2023
cancer,
immunotherapy,
neuroendocrine,
treatment,
outcomes
